Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Mbbc Stock Analysis Marathon Bancorp Inc. Gains 4.43 To Hit 14.14 Price Mark 20260403 McCormick MKC Q1 2026 Beat Revenue NA EPS Exceeds by Significant Marc Jacobs Departs LVMH After Nearly Three Decades Remains Creative Director Nerdy NRDY Falls 145 Watching 078 Support 20260515 Net Investments in Gold ETFs Turn Positive After Three Weeks of Outflows SpaceX Taps Goldman Sachs to Lead RecordBreaking IPO Sources Say Agnico Eagle AEM Stock Today Rallies 274 Resistance at 18706 20260520 Singapore Strengthens AI Ecosystem Through Global Partnerships to Drive RealWorld Applications Terra TPTA Stock Steady at 2339 Support at 2222 20260520 CNBC Investing Clubs Portfolio Rides Market Rally Top and Bottom Performers in SixWeek Record Run Rising Red Diesel Costs A UK Farmer Fears for His Sons Farming Future Spotify Surges on AI Music Collaboration with Universal Music Group and Updated Outlook Standard Chartered Targets Efficiency with Corporate Functions Restructuring and Income Growth Goals Minda Corporation Q4 Profit Surges 138 to 124 Crore Driven by Strong Demand and Focus on EV Electronics Oil Prices Edge Higher Amid Stalled Progress in USIran Nuclear Negotiations DWS Municipal Income Trust KTF Holds Steady Near 9 as Support and Resistance Levels Define Range Vine Hill Capital Investment Corp VCIC Pulls Back Sharply Key Levels Under Scrutiny Inventiva IVA Edges Higher as Shares Hold Above Key Support Zone ANSCW Warrants Hold Steady at 023 Amid Low Volatility Trump Media Warrants DJTWW Surge 4 as Bullish Momentum Emerges Advance Auto Parts AAP Slides Below 58 as Market Sentiment Weighs on Automotive Retailer GameStop GME Pulls Back Support Levels Under Scrutiny After 236 Decline Unifi Inc UFI Climbs 15 as Shares Approach Key Resistance at 424 Eaton Vance Floating Rate Income Trust EFT Edges Higher as Price Approaches Key Resistance Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny